Advertisement
Atai Beckley Inc.

Atai Beckley Inc. (ATAI) Stock Overview

Explore Atai Beckley Inc.’s financial performance, market position, analyst ratings, and future outlook.

ATAINASDAQ
HealthcareBiotechnology
$4.88
$0.39(7.40%)
U.S. Market opens in 11h 39m
Advertisement

Atai Beckley Inc. (ATAI)

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-1.64
EPS (TTM)$-0.55
ROE-3.66%
Fundamental Analysis

AI Price Forecasts

1 Month$4.62
3 Months$6.46
1 Year Target$5.77

ATAI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Atai Beckley Inc. (ATAI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.64 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.40%
5-Day Change
8.44%
1-Month Change
1.24%
3-Month Change
31.89%
6-Month Change
26.10%
Year-to-Date (YTD) Change
19.32%
1-Year Change
80.07%
3-Year Change
158.20%
5-Year Change
-72.60%
All-Time (Max) Change
-75.47%

Contact Information

332 282 0507
250 West 34th Street, New York, NY, 10119

Company Facts

990 Employees
IPO DateJun 18, 2021
CountryUS
Actively Trading

Frequently Asked Questions